Overexpression of gankyrin has been observed in several types of malignancies, such as hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer, esophageal cancer, and breast cancer10,11. Here, PSMD10 is linked to hepatocellular carcinoma.